These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 874056)
1. Effects of angiotensin II blockade by saralasin in normal man. Noth RH; Tan SY; Mulrow PJ J Clin Endocrinol Metab; 1977 Jul; 45(1):10-5. PubMed ID: 874056 [TBL] [Abstract][Full Text] [Related]
2. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency. McCaa RE Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226 [TBL] [Abstract][Full Text] [Related]
3. Adrenal responses to pharmacological interruption of the renin-angiotensin system in sodium-restricted normal man. Williams GH; Hollenberg NK; Brown C; Mersey JH J Clin Endocrinol Metab; 1978 Oct; 47(4):725-31. PubMed ID: 400731 [TBL] [Abstract][Full Text] [Related]
4. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects. Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403 [TBL] [Abstract][Full Text] [Related]
5. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension. Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810 [TBL] [Abstract][Full Text] [Related]
6. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects. Agabiti-Rosei E; Brown JJ; Brown WC; Fraser R; Trust PM; Lever AF; Morton JJ; Robertson JI Clin Endocrinol (Oxf); 1979 Mar; 10(3):227-34. PubMed ID: 455738 [TBL] [Abstract][Full Text] [Related]
7. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration. Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166 [TBL] [Abstract][Full Text] [Related]
8. Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. Wong PY; Talamo RC; Williams GH; Colman RW J Clin Invest; 1975 Apr; 55(4):691-8. PubMed ID: 235559 [TBL] [Abstract][Full Text] [Related]
9. Effect of the specific angiotensin antagonist (Sar1) (Ala8) angiotensin II on blood pressure and the renin-angiotensin system in the conscious pregnant ewe and fetus. Broughton Pipkin F; O'Brien PM Am J Obstet Gynecol; 1978 Sep; 132(1):7-15. PubMed ID: 696788 [TBL] [Abstract][Full Text] [Related]
10. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake. Carey RM; Vaughan ED; Peach MJ; Ayers CR J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631 [TBL] [Abstract][Full Text] [Related]
11. Abnormal adrenal and vascular responses to angiotensin II and an angiotensin antagonist in acromegaly. Moore TJ; Thein-Wai W; Dluhy RG; Dawson-Hughes BF; Hollenberg NK; Williams GH J Clin Endocrinol Metab; 1980 Aug; 51(2):215-22. PubMed ID: 6995474 [No Abstract] [Full Text] [Related]
12. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping. Bing RF; Russell GI; Swales JD; Thurston H J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368 [TBL] [Abstract][Full Text] [Related]
13. Changes in plasma norepinephrine after intravertebral artery infusion of saralasin in sodium depleted dogs. Arita M; Ueno Y; Suruda H; Mohara O; Nishio I; Masuyama Y Jpn Circ J; 1983 Mar; 47(3):336-41. PubMed ID: 6339771 [TBL] [Abstract][Full Text] [Related]
14. In vivo effects of angiotensin antagonists on plasma aldosterone in the dog. Beckerhoff R; Uhlschmid G; Furrer J; Nussberger J; Schmied UR; Vetter WJ; Siegenthaler W Eur J Pharmacol; 1975 Dec; 34(2):363-7. PubMed ID: 1234555 [TBL] [Abstract][Full Text] [Related]
15. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)]. Beckerhoff R; Vetter W; Furrer J; Nussberger J; Schmied U; Siegenthaler W Dtsch Med Wochenschr; 1976 Mar; 101(11):398-401. PubMed ID: 1253700 [TBL] [Abstract][Full Text] [Related]
16. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis. Schroeder ET; Anderson GH; Goldman SH; Streeten DH Kidney Int; 1976 Jun; 9(6):511-9. PubMed ID: 940284 [TBL] [Abstract][Full Text] [Related]
17. Comparative studies of the humoral and arterial pressure responses to Sar1-Ala8-, Sar1-Ile8 and Sar1-Thr8-angiotensin II in the trained unanaesthetized dog. Bravo EL; Khosla MC; Bumpus FM Prog Biochem Pharmacol; 1976; 12():33-40. PubMed ID: 1019168 [TBL] [Abstract][Full Text] [Related]
18. The influence of sar1 ala8 angiotensin II (saralasin) on plasma aldosterone in hypertensive patients. Donker AJ; van Hoogdalem P; Pratt JJ; Leenen FH Acta Med Scand; 1979; 205(3):207-12. PubMed ID: 425848 [TBL] [Abstract][Full Text] [Related]
19. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients. Mimran A; Shaldon S; Barjon P; Mion C Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368 [TBL] [Abstract][Full Text] [Related]
20. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium. Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]